Concepedia

James K. Earel

JK

5

Publications

289

Citations

5

H-Index

2005

Active since

Affiliations

University of Iowa(Current)

James K. Earel is an author at University of Iowa specializing in medicine, tumor biology, and tumor microenvironment.

Top concepts

Publications per year

2005–2009

5

Publications

5

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L

Troy J. Kemp, Aaron T. Ludwig, James K. Earel et al. · Blood · 2005 · 123 citations · Full text

Histone Deacetylase Inhibitors Modulate the Sensitivity of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Resistant Bladder Tumor Cells

James K. Earel, Rebecca L. VanOosten, Thomas S. Griffith · Cancer Research · 2006 · 80 citations

Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity

Rebecca L. VanOosten, James K. Earel, Thomas S. Griffith · APOPTOSIS · 2006 · 46 citations

, , +9

Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors

R L VanOosten, James K. Earel, T S Griffith · Cancer Gene Therapy · 2006 · 28 citations

, , +9

Synergistic Induction of Apoptosis in Primary B-CLL Cells after Treatment with Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Histone Deacetylase Inhibitors

Lyse A. Norian, Tamara A. Kucaba, James K. Earel et al. · Journal of Oncology · 2009 · 12 citations · Full text

, , +17

Rows per page

1–5 of 5